February 7, 2024
Stäfa (Switzerland), February 7, 2024 – Sonova is today opening a new facility that will house two separate operation centers for its Hearing Instruments and Cochlear Implants businesses. These will expand Sonova’s global manufacturing capabilities, provide improved supply chain security, and better serve customers throughout the strategically important Americas region.
The facility is located in an industrial area in Mexicali, Mexico, and gives access to an extensive pool of highly-skilled workers. It has been built according to LEED standards (Leadership in Energy and Environmental Design) and will provide environmental and cost-efficiency benefits, by meeting Sonova’s exact manufacturing needs. The United States headquarters for the Hearing Instruments and Audiological Care businesses will remain in Aurora, IL, and the global headquarters of the Cochlear Implants business will continue to be based in Valencia, CA.
Ludger Althoff, Group Vice President Operations of Sonova, says: “We have been very impressed with the high-quality talent we have been able to bring into our growing team in Mexico, as well as our good collaboration with the local authorities in the run-up to this opening. We will now carefully ramp up the capacity of this important facility, which will allow us to better serve hearing care professionals, and people with hearing loss across the Americas region, while meeting our sustainability goals.”
– End –
Investor Relations
Thomas Bernhardsgrütter +41 58 928 33 44
Jessica Grassi +41 58 928 33 22
ir@sonova.com
Media Relations
Karl Hanks +41 76 367 72 56
Christiane Jelinek +41 76 358 80 36
mediarelations@sonova.com
Disclaimer
This Media Release contains forward-looking statements, which offer no guarantee with regard to future performance. These statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Sonova’s control. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sonova undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.
About Sonova
Sonova is a global leader in innovative hearing care solutions: from personal audio devices and wireless communication systems to audiological care services, hearing aids and cochlear implants. The Group was founded in 1947 and is headquartered in Stäfa, Switzerland.
Sonova operates through four businesses – Hearing Instruments, Audiological Care, Consumer Hearing and Cochlear Implants – and the core brands Phonak, Unitron, AudioNova, Sennheiser (under license) and Advanced Bionics as well as recognized regional brands. The Group’s globally diversified sales and distribution channels serve an ever growing consumer base in more than 100 countries.
In the 2022/23 financial year, the Group generated sales of CHF 3.7 billion, with a net profit of CHF 658 million. Over 17,000 employees are working on achieving Sonova’s vision of a world where everyone enjoys the delight of hearing.
For more information please visit www.sonova.com.
Sonova shares (ticker symbol: SOON, Security no: 1254978, ISIN: CH0012549785) have been listed on the SIX Swiss Exchange since 1994. The securities of Sonova have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or under the applicable securities laws of any state of the United States of America, and may not be offered or sold in the United States of America except pursuant to an exemption from the registration requirements under the U.S. Securities Act and in compliance with applicable state securities laws, or outside the United States of America to non-U.S. Persons in reliance on Regulation S under the U.S. Securities Act.
AB – A Sonova Brand
©2024-2025 Advanced Bionics AG and affiliates. All rights reserved.